abagovomab 8
abciximab 21
abituzumab 10
abrilumab 12
actoxumab 8
adalimumab 9
aducanumab 5
afasevikumab 3
alacizumab_pegol 6
alemtuzumab 19
alirocumab 10
amatuximab 14
andecaliximab 12
anifrolumab 11
anrukinzumab 13
aprutumab 9
aprutumab_ixadotin 9
arcitumomab 10
ascrinvacumab 0
atezolizumab 10
atinumab 10
avelumab 7
basiliximab 14
bavituximab 11
begelomab 11
benralizumab 10
bevacizumab_beta 10
bezlotoxumab 8
bimagrumab 8
bleselumab 5
blinatumomab 16
blosozumab 23
bococizumab 14
brazikumab 7
brentuximab_vedotin 14
briakinumab 7
brodalumab 7
brolucizumab 14
brontictuzumab 14
burosumab 12
cabiralizumab 7
camrelizumab 4
canakinumab 12
cantuzumab_ravtansin 22
carlumab 12
carotuximab 8
cergutuzumab_amunaleukin2 23
cergutuzumab_amunaleukin 23
certolizumab_pegol 16
cetiximab 23
citatuzumab_bogatox 21
cixutumumab 12
clivatuzumab_tetraxetan 10
codrituzumab 18
conatumumab 9
concizumab 14
crenezumab 11
crizanlizumab 14
crotedumab 16
dacetuzumab 20
daclizumab 5
dalotuzumab 18
dapirolizumab_pegol 16
daratumumab 10
dectrekumab 4
demcizumab 18
denosumab 7
depatuxizumab 13
depatuxizumab_mafodotin 13
dezamizumab 3
dinutuximab 21
diridavumab 6
domagrozumab 9
drozitumab 7
duligotuzumab 20
durvalumab 5
dusigitumab 5
efalizumab 27
efungumab 14
eldelumab 6
elezanumab 11
elgemtumab 3
elotuzumab 10
emactuzumab 12
emapalumab 11
emibetuzumab 8
enavatuzumab 19
enfortumab_vedotin 9
enoblituzumab 15
enokizumab 16
enoticumab 9
ensituximab 10
eptinezumab 9
erenumab 7
etaracizumab 12
etrolizumab 18
evinacumab 15
evolocumab 4
farletuzumab 0
fasinumab 13
fezakinumab 10
fibatuzumab 3
ficlatuzumab 16
firivumab 21
flanvotumab 5
fletikumab 14
foralumab 4
foravirumab 11
fremanezumab 18
fresolimumab 10
fulranumab 15
futuximab 10
galcanezumab 10
ganitumab 14
gantenerumab 3
gemetuzumab 15
gemtuzumab2 18
gemtuzumab 8
gevokizumab 15
girentuximab 16
glembatumumab 15
glembatumumab_vedotin 15
guselkumab 14
ibalizumab 11
ibritumomab 10
icrucumab 7
idarucizumab 18
ifabotuzumab 3
imalumab 11
imgatuzumab 10
inclacumab 10
indatuximab_ravtansin 18
indusatumab 6
inebilizumab 13
intetumumab 3
iodine_girentuximab 18
ipilimumab 0
iratumumab 4
isatuximab 15
itolizumab 15
ixekizumab 17
labetuzumab_govitecan 16
lambrolizumab 11
lampalizumab 18
lanadelumab 15
landogrozumab 12
laprituximab 16
lebrikizumab 18
lendalizumab 21
lenzilumab 6
lifastuzumab_vedotin 15
ligelizumab 11
lilotomab 16
lirilumab 15
lodelcizumab 12
lokivetmab 11
lorvotuzumab_mertansin 10
lucatumumab 20
lumretuzumab 11
lupartumab 10
lutikizumab 9
margetuximab 22
milatuzumab 17
mirvetuximab 18
mirvetuximab_soravtansin 18
modotuximab 25
mogamulizumab 17
monalizumab 12
motavizumab 22
moxetumomab_pasudotox 14
namilumab 12
naratuximab 19
naratuximab_emtansin 19
narnatumab 8
navicixizumab2 20
navicixizumab 18
navivumab 11
necitumumab 7
nemolizumab 13
nesvacumab 14
nivolumab 7
obiltoxaximab 12
obinutuzumab 24
ocaratuzumab 12
ofatumumab 9
olaratumab 8
olokizumab 19
omalizumab 15
onartuzumab 16
ontuxizumab 8
opicinumab 13
orticumab 6
otelixizumab 18
oxelumab 7
ozanezumab 14
pamrevlumab 6
panobacumab 16
parsatuzumab 19
pasotuxizumab 16
pateclizumab 9
patritumab 9
pembrolizumab 11
perakizumab 15
pidilizumab 11
pinatuzumab_vedotin 11
plozalizumab 13
pogalizumab 9
polatuzumab_vedotin 17
ponezumab 17
prezalumab 11
pritoxaximab 19
quilizumab 15
racotumomab 16
radretumab 7
ralpancizumab 19
ramucirumab 7
ranevetmab 22
ranibizumab 7
refanezumab 14
remtolumab 10
rilotumumab 10
rinucumab 3
risankizumab 20
rituximab 3
rivabazumab 16
robatumumab 18
roledumab 9
romosozumab 10
rontalizumab 13
rosmantuzumab 10
rozanolixizumab 11
sacituzumab 20
sacituzumab_govitecan 20
samalizumab 15
sapelizumab 17
sarilumab 9
secukinumab 6
seribantumab 13
setoxaximab 23
sifalimumab 3
siltuximab 7
simtuzumab 16
sirukumab 8
solanezumab 21
solitomab 9
stamulumab 11
suptavumab 18
suvizumab 9
tabalumab 0
tadocizumab 4
tamtuvetmab 22
tanezumab 14
tarextumab 5
tavolixizumab 8
telisotuzumab 18
teplizumab 8
tesidolumab 13
tezepelumab 12
tigatuzumab 12
tildrakizumab 11
timolumab 6
tisotumab 8
tosatoxumab 19
tositumomab 10
tralokinumab 16
trastuzumab 22
tregalizumab 18
trevogrumab 7
ublituximab 12
urelumab 10
ustekinumab 20
utomilumab 16
vadastuximab 11
vadastuximab_talirin 11
vandortuzumab_vedotin 8
vantictumab 14
vanucizumab2 10
vanucizumab 8
varlilumab 13
vatelizumab 8
vedolizumab 9
veltuzumab 0
vesencumab 4
vorsetuzumab 18
vorsetuzumab_mafodotin 18
vunakizumab 19
xentuzumab 15
zatuximab 25
